Merck & Co., Inc. Current Liabilities 2008-2026 | MRK
Beta
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is Merck & Co., Inc.'s current current liabilities?
Merck & Co., Inc. (MRK) annual current liabilities for 2025 was $28.33B, a 0.33% decline from 2024. Merck & Co., Inc. current liabilities for the quarter ending March 31, 2026 was $26.95B.
What was Merck & Co., Inc.'s current liabilities in 2024?
Merck & Co., Inc. annual current liabilities for 2024 was $28.42B, a 10.61% increase from 2023.
What was Merck & Co., Inc.'s current liabilities in 2023?
Merck & Co., Inc. annual current liabilities for 2023 was $25.69B, a 6.00% increase from 2022.
What is Merck & Co., Inc.'s 5-year current liabilities CAGR?
Merck & Co., Inc. current liabilities grew at a compound annual growth rate (CAGR) of 0.72% from FY2020 to FY2025, going from $27.33B to $28.33B over 5 years.
Current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+0.7%
FY2020
$27.33B
→
FY2025
$28.33B
080910111213141516171819202122232425
5 years selected
Current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $28.33B | -0.3% | 10-K |
| FY2024 | $28.42B | +10.6% | 10-K |
| FY2023 | $25.69B | +6.0% | 10-K |
| FY2022 | $24.24B | +1.5% | 10-K |
| FY2021 | $23.87B | -12.6% | 10-K |
| FY2020 | $27.33B | +23.0% | 10-K |
| FY2019 | $22.22B | +0.1% | 10-K |
| FY2018 | $22.21B | +19.3% | 10-K |
| FY2017 | $18.61B | +8.2% | 10-K |
| FY2016 | $17.20B | -10.4% | 10-K |
| FY2015 | $19.20B | +4.4% | 10-K |
| FY2014 | $18.40B | +3.0% | 10-K |
| FY2013 | $17.87B | -2.6% | 10-K |
| FY2012 | $18.35B | +12.9% | 10-K |
| FY2011 | $16.25B | +3.9% | 10-K |
| FY2010 | $15.64B | +0.0% | 10-K |
| FY2009 | $15.64B | +9.2% | 10-K |
| FY2008 | $14.32B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →